Lanirapid and Tasigna drug interactions - a phase IV clinical study of FDA data

Summary:

Drug interactions are reported among people who take Lanirapid (metildigoxin) and Tasigna (nilotinib hydrochloride monohydrate). Common drug interactions include anaemia among females and anaemia among males.

The phase IV clinical study analyzes what interactions people have when they take Lanirapid and Tasigna. It is created by eHealthMe based on reports of 21 people who take the same drugs from the FDA, and is updated regularly.

What is Lanirapid?

Lanirapid has active ingredients of metildigoxin. eHealthMe is studying from 1,259 Lanirapid users. Check the latest studies of Lanirapid.

What is Tasigna?

Tasigna has active ingredients of nilotinib hydrochloride monohydrate. It is often used in chronic myelogenous leukemia (cml). eHealthMe is studying from 31,535 Tasigna users. Check the latest studies of Tasigna.

On Jul, 11, 2026

21 people who take Lanirapid and Tasigna together, and have interactions are studied.

Lanirapid and Tasigna drug interactions.

What are the common drug interactions of Lanirapid and Tasigna, by gender? *:

female:

Anaemia (lack of blood)
Lipase increased
Gastrointestinal haemorrhage (bleeding gastrointestinal tract)
Marasmus (severe malnutrition characterized by energy deficiency)
Eosinophil count increased
Papule
Squamous cell carcinoma of skin (a cancer of a kind of epithelial cell, the squamous cell. these cells are the main part of the epidermis of the skin)
Thrombocytopenia (decrease of platelets in blood)

male:

Anaemia (lack of blood)
Cough
Pneumonia
Subarachnoid haemorrhage (blood leaks into the space between two membranes that surround the brain)
Blood creatinine increased
Renal impairment (severely reduced kidney function)
Blast crisis in myelogenous leukaemia
Bundle branch block right (absence of transmission of electric impulses from the atrioventricular (av) bundle of his to the right ventricle)
Cardiac failure congestive
Cerebrovascular accident (sudden death of some brain cells due to lack of oxygen when the blood flow to the brain is impaired by blockage or rupture)

What are the common drug interactions of Lanirapid and Tasigna, by age (0-1 to 60+)? *:

0-1:

n/a

2-9:

n/a

10-19:

n/a

20-29:

n/a

30-39:

n/a

40-49:

n/a

50-59:

n/a

60+:

Anaemia (lack of blood)
Lipase increased
Urinary tract infection
Altered state of consciousness (altered state of mind)
Generalised erythema (redness of the skin all over the body)
Pneumonia
Subarachnoid haemorrhage (blood leaks into the space between two membranes that surround the brain)
Blood creatinine increased
Eosinophil count increased
Papule

What are the existing conditions these people have? *

Chronic Myeloid Leukaemia (long lasting type of cancer that starts in the blood-forming cells of the bone marrow and invades the blood): 21 people, 100.00%
Insomnia (sleeplessness): 3 people, 14.29%
High Blood Cholesterol: 3 people, 14.29%
Gastritis (inflammation of stomach): 3 people, 14.29%

* Approximation only. Some reports may have incomplete information.

Do you take Lanirapid and Tasigna?

- Personalize this study to your gender, age, symptoms and drugs
- Predict drug outcomes for up to one year with AI
- Get an AI agent to monitor your drugs continuously